Satellos DMD therapy - 3D animation скачать в хорошем качестве

Satellos DMD therapy - 3D animation

Learn how Satellos Bioscience's breakthrough therapy SAT-3247 is transforming treatment for Duchenne muscular dystrophy (DMD). This oral small molecule drug restores muscle regeneration by targeting AAK1 to correct muscle stem cell function, independent of dystrophin mutations. 🔬 What You'll Learn: • How SAT-3247 works to restore muscle repair in DMD patients • Clinical trial results showing doubled grip strength in 28 days • Why this dystrophin-independent approach works for all DMD mutations • The science behind muscle stem cell polarity restoration • Phase 1b trial safety data and next steps 📊 Key Clinical Results: ✓ Safe and well-tolerated in all patients ✓ Average grip strength doubled from ~2kg to ~4kg ✓ Works alongside existing steroid treatments ✓ Oral, once-daily medication 🎯 Who This Video Is For: • DMD patients and families seeking new treatment options • Healthcare providers treating Duchenne muscular dystrophy • Researchers in neuromuscular diseases • Anyone interested in regenerative medicine breakthroughs About Satellos Bioscience: Satellos is developing first-of-its-kind therapies to restore muscle regeneration in degenerative muscle diseases. Their lead drug candidate SAT-3247 is currently in clinical trials as a potential disease-modifying treatment for DMD. Important Keywords: Duchenne muscular dystrophy treatment, DMD therapy, SAT-3247, Satellos Bioscience, muscle regeneration, AAK1 inhibitor, dystrophin-independent therapy, DMD clinical trials, muscle stem cells, regenerative medicine, neuromuscular disease, orphan drug, breakthrough therapy, MyoReGenX, muscle repair 📅 Clinical Trial Information: NCT06867107 - Long-term follow-up study ongoing Phase 2 trials planned for Q3 2025 🔗 Learn More: Website: www.satellos.com Clinical Trial Info: medicalinfo@satellos.com #DuchenneMuscularDystrophy #DMD #MuscleRegeneration #ClinicalTrials #RareDiseases #SatellosTherapy #SAT3247 #RegenerativeMedicine #NeuromuscularDisease #DMDTreatment #MuscularDystrophyAwareness #BiotechInnovation #OrphanDrugs #PatientHope #MedicalBreakthrough Timestamps: 0:00 Introduction to Duchenne Muscular Dystrophy 0:30 Current DMD Treatment Challenges 1:00 How SAT-3247 Works 2:00 Clinical Trial Design 3:00 Results and Patient Outcomes 4:00 Future Plans and Hope for DMD Patients